Health Services
Conditions
Keywords
family medicine group, pharmacists, primary health care, pharmaceutical services, interprofessional relations
Brief summary
The project objective is to evaluate the impact of the recent addition of pharmacists within family medicine groups (FMGs) on organizational and clinical parameters. The process by which changes occur and the level of pharmacists' activities will also be assessed. The ultimate goal of the project is the development of an accompanying guide to facilitate the work of the pharmacist in monitoring complex patients in primary care medical clinics.
Interventions
OTHERPharmacist clinical intervention
Pharmacists will make a clinical intervention with patients. They will review patient drug therapy already prescribed in their usual care. This includes a medication reconciliation, an assessment of drug related problems, an assessment of the regimen complexity and adherence to treatment. A care plan will be elaborated. Moreover, immediate and future interventions with the patient or other health professionals will be implemented and monitored. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.
Sponsors
McGill University
Fonds de la Recherche en Santé du Québec
Université de Sherbrooke
Laval University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Willing to meet with the pharmacist and; * Consuming drugs of four or more different pharmacological classes or having to take at least four doses per day and; * aged 70 or over with at least two criteria of vulnerability or aged less than 70 with at least 3 criteria of vulnerability or had a recent loss of autonomy or in post- hospitalization with medication changes in the hospital.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of drug related problems | 3 to 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Regimen complexity | 3 to 6 months | Medication regimen complexity index (MRCI) |
| Medication adherence | 3 to 6 months | Proportion of days covered (PDC) |
| Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.) | 3 to 6 months | Quality indicators (proposed by INESSS) |
Countries
Canada
Outcome results
None listed